Fresenius SE & Co. KGaA: Fresenius expects meaningful positive effects from US tax reform
Fresenius SE & Co. KGaA / Key word(s): Miscellaneous
Fresenius expects meaningful positive effects from US tax reform
The new legislation triggers the revaluation of deferred tax liabilities. This results in a one-time book gain of approximately EUR 90 million, to be reflected in Fresenius' 2017 Group net income*. Thereof, approximately EUR 30 million are attributable to Fresenius Kabi and approximately EUR 60 million** to Fresenius Medical Care.
Fresenius will report FY17 results and provide FY18 guidance, including details on recurring tax effects resulting from the US tax reform, on February 27, 2018.
Fresenius SE & Co. KGaA,
Bad Homburg v.d.H., 22 December 2017
* Net income attributable to shareholders of Fresenius SE & Co. KGaA
|Company:||Fresenius SE & Co. KGaA|
|61352 Bad Homburg v.d.H.|
|Phone:||+49 (0)6172 608-2485|
|Fax:||+49 (0)6172 608-2488|
|Listed:||Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxemburg|
|End of Announcement||DGAP News Service|